REGULATED PRESS RELEASE published on 06/10/2024 at 08:18, 2 years 1 month ago Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité Biophytis annonce le dépôt d'une demande d'IND pour son étude de phase 2 dans l'obésité auprès de la FDA. L'étude évalue l'efficacité de BIO101 chez des patients obèses et en surpoids FDA Biophytis Étude De Phase 2 BIO101 Obésité
REGULATED PRESS RELEASE published on 06/10/2024 at 08:18, 2 years 1 month ago Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity Biophytis files IND application with US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone) to assess muscle strength improvement in lower limbs and secondary endpoints like mobility and body composition FDA Biophytis BIO101 IND Application Obesity Study
PRESS RELEASE published on 06/10/2024 at 08:16, 2 years 1 month ago Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité FDA Biophytis Étude De Phase 2 Obésité Demande D'IND
PRESS RELEASE published on 06/10/2024 at 08:16, 2 years 1 month ago Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity Biophytis submits IND application to US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone). Study to assess muscle strength & body composition. Research led by Professor Marc-André Cornier Biophytis BIO101 IND Application Obesity Study Professor Marc-André Cornier
BRIEF published on 06/07/2024 at 08:28, 2 years 2 months ago Assemblée générale mixte de Biophytis le 24 juin 2024 Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
BRIEF published on 06/07/2024 at 08:28, 2 years 2 months ago Biophytis Announces Combined General Meeting on June 24, 2024 Shareholders Biophytis General Meeting Voting Agenda
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 2 years 2 months ago Assemblée générale mixte du 24 juin 2024 Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 2 years 2 months ago Combined General Meeting of June 24, 2024 Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website Shareholders Voting Combined General Meeting Biophytis SA CGM
BRIEF published on 06/07/2024 at 07:44, 2 years 2 months ago Assemblée générale mixte de Biophytis prévue le 24 juin 2024 Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF published on 06/07/2024 at 07:44, 2 years 2 months ago Biophytis Combined General Meeting scheduled for June 24, 2024 Shareholders Biophytis Paris General Assembly Vote
Published on 08/07/2026 at 23:15, 1 day 15 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 15 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 15 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 16 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/09/2026 at 00:01, 14 hours 19 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 21 hours 54 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 14 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 19 hours ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:54, 1 day 19 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 19 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 19 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 19 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 20 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026